New York Times Sues HRSA To Release 340B Data, Communications Between Office of Pharmacy Affairs and Apexus Leaders; Information Could Be Released Soon

A federal court sided with a group of Texas hospitals’ efforts to block an HHS rule.
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days Before New Laws Go Into Effect, GSK, Pfizer Exempt Additional States from Contract Pharmacy Restrictions

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Navigating HRSA 340B Program Audits

SPONSORED CONTENT

In the complex landscape of healthcare, compliance with the Health Resources and Services Administration’s (HRSA) 340B program is paramount for covered entities. As organizations strive to optimize their participation in the program, one critical aspect is preparing for HRSA audits. To shed light on this crucial process, we

Read More »

Health Centers Fear ‘Collateral Damage’ From New Manufacturer Restrictions on Wholly-Owned Pharmacies

Ohio-based Signature Health will lose 340B drug access at its fully owned central fill pharmacy as a result of five new drugmaker policies.
Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Centers Urge Federal Appeals Court to Reverse Dismissal of Suit Alleging Drugmaker Collusion on Contract Pharmacy Restrictions

Rochester, N.Y.-based Mosaic Health and Central Virginia Health Services filed a June 10 appeal brief with the U.S. 2nd Circuit Court of Appeals.
Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Association Pans ASAP 340B-Endorsed Bill, Encourages Congress to Support 340B PATIENTS Act

California
The California Hospital Association argued in a June 20 letter to the state’s congressional delegation that “core provisions” of the 340B Affording Care for Communities and Ensuring a Strong Safety-Net (340B ACCESS) Act “will reduce access to care for vulnerable populations.”
The California Hospital Association (CHA) is the latest organization to raise concerns about the 340B ACCESS Act, a bill recently [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Nick Gnadt, Director of Pharmacy Professional Services, SpendMend

Nick Gnadt

Q: Where did you grow up?

Slinger, Wisconsin.  It’s a small town north of Milwaukee.  If you’ve heard of it, it’s probably either because of Little Switzerland (small ski hill) or the Slinger Super Speedway (racetrack).

Q: Where did you go to college/graduate school?

I’m a Badger through and through – I went to undergraduate and Pharmacy School

Read More »

Expert Tip from Cervey

img
img

TIP: Enhance your 340B program efficiency through collaborative review and impact analysis.


Asking your TPA

Read More »

Exclusive

Key West Virginia Lawmaker Considering Legal Action Against Anti-340B PAC Taking Credit for his Election Loss

West Virginia Senate President Craig Blair (R), who also serves as the state’s lieutenant governor, told 340B Report that he’s weighing potential litigation against Stand for Us PAC, which has claimed credit for the GOP leader’s May 14 primary loss. (Photo courtesy: WV Senate.)
A prominent West Virginia Republican is considering taking legal action after a political action committee (PAC) reportedly spent $400,000-plus against [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

IRA Could ‘Crush the 340B Margin,’ Force Transparency into Program, Says Adam Fein of Drug Channels

Adam Fein, Ph.D., president of Drug Channels Institute, hosted a June 21 webinar that discussed the IRA's interaction with the 340B program.

The Inflation Reduction Act (IRA) may reduce 340B margins for certain high-cost drugs and drive more transparency into the program, an influential pharmaceutical supply chain analyst who has been a frequent 340B critic told an audience of stakeholders late last

Read More »